Thuja promotes Lisanne Blauw to Associate
We are pleased to announce that Lisanne Blauw has been promoted to Associate as per January 1st. Lisanne has started with Thuja a little less than two years ago as an Investment Analyst.
Prior to joining Thuja she held a postdoc position at the University of Twente and the Leiden University Medical Center (LUMC). During her postdoc, she focused on the development of heart-on-a-chip models for drug discovery and co-founded a start-up company (River Biomedics) in this space. Lisanne holds a BSc degree in Medicine (Leiden University Medical Center, LUMC), a MSc degree in BioMedical Engineering (Delft University of Technology) and a PhD in Medicine (LUMC).
Michel Briejer, Managing Partner at Thuja: “We have been impressed by the steep growth we have witnessed since Lisanne joined us. In addition, she is a true asset to the team and a joy to work with as a person.”
Lisanne meanwhile has joined the Supervisory Boards of EsoBiotec and Fundamental Pharma, in each case as an observer.